One place to check GMI — literature, patents, and regulatory status
GMIBIO brings together the published research, patent families, and regulatory registrations for GMI (Ganoderma microsporum immunomodulatory protein) and its derivative eExo-GMI® — across food, cosmetic, animal-health and drug-development applications.
GMI — Ganoderma microsporum immunomodulatory protein
A fungal immunomodulatory protein (FIP) from Ganoderma microsporum, produced recombinantly in Pichia pastoris. In the scientific and patent literature for over 20 years; registered as a food, cosmetic and drug-substance ingredient in multiple jurisdictions.
Also known as: GMI、FIP-gmi、GMIP、Fungal immunomodulatory protein from Ganoderma microsporum、小孢子靈芝免疫調節蛋白、小孢子靈芝類球蛋白、Pichia r-Ganoderma Microsporum Polypeptide-1 Ferment Filtrate Extract
Identifiers
| Wikidata | Q110625259 |
|---|---|
| UniProt | E7FH75 |
| PDB | 3KCW |
| GenBank | AGU04723.1 |
| PubChem SID | 461501955 |
| NCI NSC | NSC767593 |
| US PCPC INCI | 35581 |
| EU COSING | 99091 |
| Japan JCIA | 567713 |
| US FDA NDI | 1133 |
eExo-GMI® — GMI encapsulated in Pichia extracellular vesicles
GMI encapsulated in Pichia (yeast) extracellular vesicles — a distinct derivative formulation of GMI, developed primarily for cosmetic applications.
Also known as: eExo-GMI®、Pichia/Ganoderma Microsporum Polypeptide-1 Extracellular Vesicles、霊芝外泌體
Identifiers
Regulatory registrations
10 entries across food, cosmetic and drug-substance frameworks, each linked to its official source.
→Built for four kinds of readers
- 01
Internal alignment
A single, shared view of the literature, patents and regulatory status across functional groups.
- 02
First-time researchers
For R&D staff and academics discovering GMI through search — what it is, and what has been published.
- 03
Business development
Pre-read material before a 1-on-1 meeting, organized by application area.
- 04
Data-room review
Self-service review of publicly available registration and literature data.